Monday, December 1, 2008 - 11:54PM EST

Drug Therapy

1. Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR.

Author
Hoeldtke RD; Bryner KD; Hoeldtke ME; Hobbs G;
Institution
Dept. of Medicine, West Virginia University, One Medical Center Drive, PO Box 9159, Morgantown, WV 26506-9159, USA. rhoeldtke@hsc.wvu.edu
Journal
Clin Auton Res. 2007 Dec;17(6):334-40. Epub 2007 Aug 31.
Abstract URL
Click here to view abstract

2. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy.

Author
Kawagashira Y; Watanabe H; Oki Y; Iijima M; Koike H; Hattori N; Katsuno M; Tanaka F; Sobue G;
Institution
Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Journal
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):899-901.
Abstract URL
Click here to view abstract

3. Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients.

Author
Leger JM; Viala K; Cancalon F; Maisonobe T; Gruwez B; Waegemans T; Bouche P; Leger JM; Viala K; Cancalon F; Maisonobe T; Gruwez B; Waegemans T; Bouche P;
Institution
Department of Neurology, Hopital de la Salpetriere, Paris, France. jean-marc.leger@psl.aphp-paris.fr
Journal
J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):93-6.
Abstract URL
Click here to view abstract

4. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

Author
Moulin DE; Clark AJ; Gilron I; Ware MA; Watson CP; Sessle BJ; Coderre T; Morley-Forster PK; Stinson J; Boulanger A; Peng P; Finley GA; Taenzer P; Squire P; Dion D; Cholkan A; Gilani A; Gordon A; Henry J; Jovey R; Lynch M; Mailis-Gagnon A; Panju A; Rollman GB; Velly A;
Institution
University of Western Ontario, London, Ontario, Canada. dwight.moulin@lhsc.on.ca
Journal
Pain Res Manag. 2007 Spring;12(1):13-21.
Abstract URL
Click here to view abstract

5. Neuroactive steroids and peripheral neuropathy.

Author
Roglio I; Giatti S; Pesaresi M; Bianchi R; Cavaletti G; Lauria G; Garcia-Segura LM; Melcangi RC; Roglio I; Giatti S; Pesaresi M; Bianchi R; Cavaletti G; Lauria G; Garcia-Segura LM; Melcangi RC;
Institution
Department of Endocrinology and Center of Excellence on Neurodegenerative Diseases, University of Milan, Via Balzaretti 9, 20133, Milan, Italy.
Journal
Brain Res Rev. 2008 Mar;57(2):460-9. Epub 2007 May 6.
Abstract URL
Click here to view abstract

6. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.

Author
Terneus W;
Institution
, 708 Bayfront Terrace, Sebastian FL, 32, william.terneus@irmh.org.
Journal
J Pain Palliat Care Pharmacother. 2007;21(1):79-84.
Abstract URL
Click here to view abstract

7. Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence.

Author
Granot R; Day RO; Cohen ML; Murnion B; Garrick R;
Institution
Therapeutics Center, St Vincent's Hospital, Darlinghurst, NSW, Australia.
Journal
Pain Med. 2007 Jan-Feb;8(1):48-64.
Abstract URL
Click here to view abstract

8. Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain.

Author
Liberatore AM; Schulz J; Favre-Guilmard C; Pommier J; Lannoy J; Pawlowski E; Barthelemy MA; Huchet M; Auguet M; Chabrier PE; Bigg D;
Institution
Ipsen Research Laboratories, Institut Henri Beaufour, 5 avenue du Canada, 91966 Les Ulis Cedex, France. anne-marie.liberatore@ipsen.com
Journal
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1746-9. Epub 2006 Dec 22.
Abstract URL
Click here to view abstract

9. Antiepileptic drugs in the treatment of neuropathic pain.

Author
Eisenberg E; River Y; Shifrin A; Krivoy N;
Institution
Pain Relief Unit, Rambam Medical Center, Haifa, IsraelThe B. Rappaport Faculty of Medicine, The Technion - Israel Institute of Technology, Haifa, Israel.
Journal
Drugs. 2007;67(9):1265-89.
Abstract URL
Click here to view abstract